Excessive hypotension was seen in 0.4% of patients treated with EXFORGE.
应用Exforge治疗的患者中有0.4%患者出现许血压过低。
Taking EXFORGE during pregnancy can cause injury and even death to your unborn baby.
怀孕期间服用Exforge可造成胎儿损伤甚至死亡。
EXFORGE is contraindicated in patients who are hypersensitive to amlodipine or valsartan.
Exforge禁用于对缬沙坦或氨氯地平敏感患者。
The US approval of Exforge was supported by an extensive clinical program involving more than 5,000 patients(1).
Exforge获得美国批准是基于有5000名患者参与的一项大规模临床研究项目结果的支持。
In patients with renal artery stenosis or severe renal impairment, care should be exercised with dosing of EXFORGE.
对于肾动脉狭窄或严重肾功能损害患者，应注意Exforge剂量调整。
Exforge was approved in January 2007 in the European Union and has already been made available in nine EU countries, including Germany and the UK, with further launches planned.
Exforge已于2007年1月获欧盟批准，并已在包括德国和英国在内的欧盟9国上市，进一步的上市计划也在进行中。
Exforge was approved in January 2007 in the European Union and has already been made available in nine EU countries, including Germany and the UK, with further launches planned.
Exforge已于2007年1月获欧盟批准，并已在包括德国和英国在内的欧盟9国上市，进一步的上市计划也在进行中。
应用推荐